New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study.

Saved in:
Bibliographic Details
Title: New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study.
Authors: Guardiola-Ripoll M; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain., Almodóvar-Payá C; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain., Lubeiro A; Psychiatry Department, School of Medicine, University of Valladolid, Valladolid, Spain., Salvador R; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain., Salgado-Pineda P; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain., Gomar JJ; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; The Litwin-Zucker Alzheimer's Research Center, NY, United States., Guerrero-Pedraza A; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; Hospital Benito Menni-CASM, Sant Boi de Llobregat, Barcelona, Spain., Sarró S; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain., Maristany T; Diagnostic Imaging Department, Hospital Sant Joan de Déu Research Foundation, Barcelona, Spain., Fernández-Linsenbarth I; Psychiatry Department, School of Medicine, University of Valladolid, Valladolid, Spain., Hernández-García M; Neurosciences Institute of Castilla y León (INCYL), University of Salamanca, Salamanca, Spain., Papiol S; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany; Department of Psychiatry, University Hospital, Ludwig Maximilian University, Munich Germany., Molina V; Psychiatry Department, School of Medicine, University of Valladolid, Valladolid, Spain; Neurosciences Institute of Castilla y León (INCYL), University of Salamanca, Salamanca, Spain; Psychiatry Service, University Hospital of Valladolid, Valladolid, Spain., Pomarol-Clotet E; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain. Electronic address: epomarol-clotet@fidmag.com., Fatjó-Vilas M; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain; CIBERSAM (Biomedical Research Network in Mental Health, Instituto de Salud Carlos III), Madrid, Spain; Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona; Barcelona, Spain. Electronic address: mfatjo-vilas@fidmag.com.
Source: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2022 Jul; Vol. 60, pp. 38-47. Date of Electronic Publication: 2022 May 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7862
DOI:10.1016/j.euroneuro.2022.04.012